Search Results < Neurology

2502 results

News
The Brain’s Drainage System in 3 Dimensions
Meningeal lymphatic vessels are potential targets to treat brain diseases. Laboratories at Yale and the Paris Brain Institute (Pitié-Salpêtrière Hospital, Paris) image brain drainage by meningeal lymphatics in mice and in humans.
19 Jul 2022
News
Yale Researcher Studies Alzheimer's Disease
Dr. Carolyn Fredericks of Yale School of Medicine talks about what is involved when volunteering for brain research on Alzheimer's disease.
13 Jun 2022
News
Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
24 May 2022
News
The Brain and the Heart: Understanding How to Prevent and Treat Alzheimer’s Disease
Can we predict who will develop Alzheimer’s disease and other dementias? Can we identify biomarkers to predict disease development early? What are the most promising treatment targets?
11 Apr 2022
News
Yale Investigators Link Higher Levels of Low Density Cholesterol With Decreased Risk of Subarachnoid Hemorrhage
A team of Yale investigators is evaluating whether elevated lipid levels - generally considered to be detrimental to human health due to their effect on cardiovascular disease - can have protective effects on the brain.
2 Nov 2021
News
WHRY Now Accepting Letters of Intent for Pilot Projects on Women's Health
WHRY is now accepting letters of intent for studies that advance our understanding of the health of women and/or sex/gender differences that influence health.
7 Sep 2021
News
Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin
An exploratory study by Yale researchers found there is an enduring therapeutic effect in migraine headache after a single administration of psilocybin.
Source: Neurotherapeutics
15 Nov 2020
News
WHRY Launches Studies on Endometrial Cancer, Addiction to Opioids, and Stroke
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
5 Oct 2020
News
Will We Ever Find a Cure for Dementia?
Christopher Van Dyck, MD, Professor of Psychiatry and Director of the Alzheimer's Disease Research Unit at Yale School of Medicine, spoke to AARP about research into the treatment of Alzheimer's disease.
Source: AARP
26 Jun 2020
News
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
20 May 2020
News
New Imaging Tool Helps Researchers See Extent of Alzheimer’s Early Damage
New imaging technology allows scientists to see the widespread loss of brain synapses in early stages of Alzheimer’s disease, a finding that one day may aid in drug development, according to a new Yale University study.
Source: Yale News
14 May 2020
News
HIV DNA That Lingers in Spinal Fluid May Be Linked to Cognitive Problems
Even in patients who receive long-term anti-retroviral treatment, cells containing HIV remain in the cerebrospinal fluid of half of those treated for the disease, and those individuals are more likely to experience cognitive deficits than those without cells that have HIV, a new study has found.
15 Jul 2019
News
Department of Neurology Receives Major Grant to Evaluate Blood Thinners and Stroke Prevention
Yale School of Medicine has received a 5-year, $20 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to administer a Phase III trial measuring the effectiveness of using a blood thinner to prevent new strokes in patients who suffered brain hemorrhages and have atrial fibrillation, or irregular heartbeat.
3 Jul 2019
News
Lowering Blood Pressure Reduces Brain Bleeding in Strokes
A new study suggests that intensive blood pressure lowering may reduce the amount of bleeding in deep areas of the brain in patients with the most devastating form of stroke, a team of Yale researchers reports.
14 May 2019
News
Rakic awarded 2019 Connecticut Medal of Science
The State of Connecticut and Connecticut Academy of Science and Engineering have awarded the 2019 Connecticut Medal of Science to Pasko Rakic, MD, PhD, Dorys McConnell Duberg Professor of Neuroscience and Professor of Neurology at Yale School of Medicine.
12 Apr 2019
News
Nine From Medical School Are Among 13 Yale Faculty Named to Connecticut Academy of Science and Engineering
The Connecticut Academy of Science and Engineering has elected 24 new members. Thirteen are Yale faculty members, of whom nine have appointments at the School of Medicine.
19 Feb 2019
News
New Compound Shows Promise in Treatment of Alzheimer’s
Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s and even restores memories in mice, they report in the journal Cell Reports.
6 Jan 2019
News
Gene Variant Found in Brain Complicit in MS Onset
Yale scientists report that genetic risk variants can affect the function of brain cells, which then become complicit in triggering multiple sclerosis.
16 Dec 2018
News
How salt can trigger inflammation in multiple sclerosis
Researchers at Yale have identified a high-salt environment as one of the contributing factors to the development of multiple sclerosis (MS).
29 Oct 2018
News
New Alzheimer’s drug undergoing trials at two Connecticut sites
A new approach to treating Alzheimer’s disease is being tested in a clinical trial with strong New Haven connections.
Source: The New Haven Register
21 Oct 2018